Amlodipine vs amlodipine besylate efficacy
Pro Research Analysisby 
Searched over 200M research papers
Efficacy Comparison: Amlodipine vs. Amlodipine Besylate in Hypertension Treatment
Blood Pressure Control Efficacy: Amlodipine Mesylate vs. Amlodipine Besylate
Studies comparing amlodipine mesylate and amlodipine besylate in patients with essential hypertension found both forms to be highly effective in lowering blood pressure. The total effective rates were 97% for amlodipine mesylate and 96% for amlodipine besylate, with no significant difference between the two. Both formulations were also well tolerated, with only mild side effects such as headache and facial flushing reported .
Efficacy of Amlodipine Besylate: Monotherapy and Combination Therapy
Amlodipine besylate, whether used alone or in combination with other antihypertensive agents, consistently demonstrates significant reductions in both systolic and diastolic blood pressure. Studies show that amlodipine besylate is effective as monotherapy and as an add-on therapy, with substantial blood pressure reductions and a high rate of patients achieving target blood pressure goals 7610. When compared to other antihypertensive drugs or in combination regimens, amlodipine besylate maintains a strong efficacy profile 698.
L-Amlodipine Besylate and Dose Response
Research on L-amlodipine besylate indicates that higher doses (5 mg/day) are more effective in controlling blood pressure than lower doses (2.5 mg/day), with response rates of 85.6% and 72.4% respectively. The efficacy of low-dose L-amlodipine besylate is similar to that of amlodipine maleate, and all regimens have comparable safety profiles .
Amlodipine Besylate vs. Other Amlodipine Salts
Direct comparisons between amlodipine besylate and other amlodipine salts, such as amlodipine maleate and amlodipine mesylate, show no significant differences in blood pressure-lowering efficacy or safety. Both forms are effective and well tolerated in patients with mild to moderate hypertension 134.
Safety and Tolerability
Across multiple studies, amlodipine besylate is consistently reported as safe and well tolerated, with a low incidence of adverse events. The most common side effects are mild, such as headache and peripheral edema, and there are no significant differences in safety between different amlodipine salts or between domestic and imported formulations 14105.
Conclusion
Current research indicates that amlodipine besylate and other amlodipine salts, such as mesylate and maleate, have equivalent efficacy and safety profiles in the treatment of mild to moderate hypertension. Both forms effectively lower blood pressure and are well tolerated, making them suitable options for hypertension management. There is no significant difference in clinical outcomes between amlodipine besylate and other amlodipine formulations.
Sources and full results
Most relevant research papers on this topic